Lipid deposition, mononuclear cell infiltration and accumulation of me
sangial matrix components are recognized as early events in the develo
pment of glomerulosclerosis whilst correction of plasma lipid abnormal
ities slows the progression of renal disease in experimental models. I
n vitro studies have demonstrated that low density lipoprotein (LDL) i
s bound and internalized by mesangial cells, acts synergistically with
growth factors to stimulate cellular proliferation and modifies secre
tion of chemotactic mediators and matrix components. LDL incubated wit
h mesangial cells becomes oxidized and in this modified from inhibits
cell proliferation and causes cytotoxic injury. Oxidation of LDL also
modulates its effects on cell secretory function. Since proteoglycans
secreted by mesangial cells bind LDL particles, excess matrix accumula
tion may exacerbate lipoprotein-mediated injury. These findings sugges
t that lipoproteins deposited and oxidized in the glomerulus may promo
te inflammation, cell injury and sclerosis.